Victoria Barghout, MSPH

home / authors / victoria-barghout-msph

Articles

Site Logo
April 15th 2005

Tegaserod Treatment for IBS: A Model of Indirect Costs

Dean G. Smith, PhD Victoria Barghout, MSPH Kristijan H. Kahler, SM

Site Logo
April 15th 2005

Effectiveness of Tegaserod Therapy on GI-related Resource Utilization in a Managed Care Population

Judith J. Stephenson, SM Victoria Barghout, MSPH Kristijan H. Kahler, SM Joaquim Fernandes, BA Jane F. Beaulieu, MSN Samuel Joo, MS Stephen J. Boccuzzi, PhD

Site Logo
April 15th 2005

Total Costs of IBS: Employer and Managed Care Perspective

Brooks Cash, MD, FACP Sean Sullivan, JD Victoria Barghout, MSPH

Site Logo
April 15th 2005

Budget Impact of Tegaserod on a Managed Care Organization Formulary

Michael A. Bloom, BA Victoria Barghout, MSPH Kristijan H. Kahler, SM Judith Bentkover, PhD Hannah Kurth, BA Ian M. Gralnek, MD, MSHS Brennan M. R. Spiegel, MD, MSHS

Site Logo
April 15th 2005

Impairment in Work Productivity and Health-related Quality of Life in Patients With IBS

Bonnie B. Dean, PhD Daniel Aguilar, MPH Victoria Barghout, MSPH Kristijan H. Kahler, SM Feride Frech, MPH David Groves, PhD Joshua J. Ofman, MD

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Alfred L. Garfall, MD, an expert on multiple myeloma
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo